Study of Metoclopramide in Small Bowel Capsule Endoscopy
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
Patients undergoing small bowel capsule endoscopy will be randomized into 3 study groups to
either receive 5 mg of metoclopramide, 10 mg of metoclopramide, or a placebo 30 minutes prior
to swallowing the Pill Cam. This is a randomized, double-blind, placebo-controlled design.
The outcomes to be assessed are capsule study completion rates, gastric transit time, small
bowel transit time, and the effect of diabetes on pill capsule completion rates. The purpose
of the study is to assess if metoclopramide given prior to pill capsule endoscopy has any
effect on pill capsule completion rate, gastric transit time, small bowel transit time, and
pill capsule completion rates in diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Ascension Genesys Hospital Genesys Regional Medical Center